USP订购编号 |
美国药典,USP分析标准品,英文名称,规格 |
CAS编号查询 |
UN编号对照 |
USP-1643361 |
Taurine (100 mg) |
107-35-7 |
|
2921196190 |
|
|
|
USP-1643383 |
Tazobactam (200 mg) |
89786-04-9 |
|
2941106000 |
|
|
|
USP-1643394 |
Tazobactam Related Compound A (20 mg) ((2S,3S)-2-Amino-3-methyl-3-sulfino-4-(1H-1,2,3-triazol-1-yl)butyric acid) |
118175-11-4 |
|
2933999552 |
|
|
|
USP-1643419 |
Telmisartan (200 mg) |
144701-48-4 |
UN3077 |
USP-1643420 |
Telmisartan Related Compound A (20 mg) (1,7′-dimethyl-2′-propyl-1H,3’H-2,5′-bibenzo[d]imidazole monohydrate) |
1282554-35-1 |
|
2933998350 |
|
|
|
USP-1643703 |
Terconazole (200 mg) |
67915-31-5 |
|
2934990005 |
|
|
|
USP-1643736 |
Teniposide (200 mg) |
29767-20-2 |
UN2811 |
USP-1643747 |
Teniposide Related Compound A (10 mg) (4′-Demethylepipodophyllotoxin) |
6559-91-7 |
|
2932996560 |
|
|
|
USP-1643962 |
Teriparatide (1 mg) (需冷链运输) |
52232-67-4 |
|
2937190000 |
|
|
|
USP-1643984 |
Terminalia chebula Fruit Dry Extract (1 g) |
N/A |
|
1302190200 |
|
|
|
USP-1644003 |
Terpin Hydrate (750 mg) |
2451/1/6 |
|
2906195000 |
|
|
|
USP-1644319 |
Temazepam Related Compound A (15 mg) (5-chloro-2-methylaminobenzophenone) |
1022-13-5 |
|
2933999552 |
|
|
|
USP-1650028 |
Tetracaine Related Compound C (25 mg) (Methyl 4-(butylamino)benzoate) |
71839-12-8 |
|
2922493800 |
|
|
|
USP-1651654 |
2,3,5,4′-Tetrahydroxystilbene-2-O-Beta-D-Glucoside (50 mg) ((E)-2,4-dihydroxy-6-(4-hydroxystyryl)phenyl beta-D-glucopyranoside) |
82373-94-2 |
|
2938900000 |
|
|
|
USP-1652001 |
Tetrahydrozoline Hydrochloride (200 mg) |
522-48-5 |
|
2933290000 |
|
|
|
USP-1652023 |
Tetrahydrozoline Related Compound B (25 mg) (2-(1,2,3,4-Tetrahydronaphthalen-1-yl)-1H-imidazole) |
945389-41-3 |
|
2933290000 |
|
|
|
USP-1652034 |
Tetrahydrozoline Related Compound C (25 mg) (1,2,3,4-Tetrahydronaphthalene-1-carboxylic acid) |
1914-65-4 |
|
2916399000 |
|
|
|
USP-1652045 |
Tetrahydrozoline Related Compound D (25 mg) (2-(Naphthalen-1-yl)-4,5-dihydro-1H-imidazole hydrochloride) |
13623-57-9 (free base) |
|
2933290000 |
|
|
|
USP-1652056 |
Tetrahydrozoline Related Compound E (25 mg) (N-(2-Aminoethyl)-1,2,3,4-tetrahydronaphthalene-1-carboxamide) |
84460-89-9 |
|
2924296000 |
|
|
|
USP-1652158 |
Tetraxetan (50 mg) |
60239-18-1 |
|
2933999552 |
|
|
|
USP-1652169 |
Tetraxetan Related Compound A (25 mg) (2,2′,2″-[10-(2-Ethoxy-2-oxoethyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl]triacetic acid) |
2101625-18-5 |
|
2933999552 |
|
|
|
USP-1076363 |
Brinzolamide (200 mg) |
138890-62-7 |
|
2935904000 |
|
|
|
USP-1076374 |
Brinzolamide Related Compound A (50 mg) ((S)-4-(Ethylamino)-2-(3-methoxypropyl)-3,4-dihydro-2H-thieno[3,2-e] [1,2]thiazine-6-sulfonamide 1,1-dioxide), (Brinzolamide (S)-Isomer)) |
154127-19-2 |
|
2935909550 |
|
|
|
USP-1076385 |
Brinzolamide Related Compound B (50 mg) ((R)-4-Amino-2-(3-methoxypropyl)-3,4-dihydro-2H-thieno[3,2-e][1,2]thiazine-6-sulfonamide 1,1-dioxide oxalate) |
N/A |
|
2935909550 |
|
|
|
USP-1076400 |
Brimonidine Tartrate (250 mg) |
70359-46-5 |
UN2811 |
USP-1076419 |
Brimonidine Related Compound A (50 mg) (5-Bromoquinoxalin-6-amine) |
50358-63-9 |
|
2933997500 |
|
|
|
USP-1076421 |
Brimonidine Related Compound B (50 mg) (1-(5-Bromoquinoxalin-6-yl)thiourea) |
842138-74-3 |
|
2933997500 |
|
|
|
USP-1076454 |
Brimonidine Related Compound E (15 mg) (2-(5-Bromoquinoxalin-6-yl)guanidine dihydrochloride) |
N/A |
|
2933998350 |
|
|
|
USP-1076501 |
Bromocriptine Mesylate (150 mg) |
22260-51-1 |
UN3077 |
USP-1077005 |
Bromodiphenhydramine Hydrochloride (200 mg) |
1808-12-4 |
|
2922190900 |
|
|
|
USP-1077708 |
8-Bromotheophylline (400 mg) |
10381-75-6 |
|
2939590000 |
|
|
|
USP-1077774 |
Broccoli Seed Dry Extract (350 mg) |
N/A |
|
1302190200 |
|
|
|
USP-1077887 |
Bromperidol Decanoate (15 mg) |
75067-66-2 |
|
2933399095 |
|
|
|
USP-1078008 |
Brompheniramine Maleate (125 mg) |
980-71-2 |
|
2933399095 |
|
|
|
USP-1078201 |
Budesonide (200 mg) |
51333-22-3 |
|
2937290000 |
|
|
|
USP-1086108 |
Calcifediol (75 mg) |
63283-36-3 |
UN2811 |
USP-1086141 |
Calcipotriene (200 mg) |
112965-21-6 |
UN2811 |
USP-1086152 |
Calcipotriene Related Compound C (15 mg) ((5E,7E,22E,24S)-24-Cyclopropyl-9,10-secochola-5,7,10(19),22-tetraene-1alpha,3beta,24-triol) |
113082-99-8 |
UN2811 |
USP-1086301 |
Calcitriol (10 mg) (需冷链运输) |
32222-06-3 |
UN2811 |
USP-1086334 |
Calcium Acetate (500 mg) |
62-54-4 |
|
2915299000 |
|
|
|
USP-1086356 |
Calcium Ascorbate (200 mg) |
5743-28-2 |
|
2936270000 |
|
|
|
USP-1086378 |
Calcium Benzoate (200 mg) |
5743-30-6 |
|
2916310002 |
|
|
|
USP-1086403 |
Calcium Carbonate (1 g) |
471-34-1 |
|
2836500000 |
|
|
|
USP-1086414 |
Calcium Citrate (500 mg) |
5785-44-4 |
|
2918150000 |
|
|
|
USP-1086425 |
Calcium Citrate Malate (200 mg) |
142606-53-9 |
|
2918195000 |
|
|
|
USP-1086436 |
Calcium Chloride (1 g) |
10035-04-8 |
|
2827200000 |
|
|
|
USP-1086447 |
Calcium Cyclamate (200 mg) |
5897-16-5 (dihydrate); 139-06- |
|
2929909000 |
|
|
|
USP-1086800 |
Calcium Gluceptate (200 mg) |
29039-00-7 |
|
2918195000 |
|
|
|
USP-1086822 |
Calcium Gluconate Anhydrous (200 mg) |
299-28-5 |
|
2918160000 |
|
|
|
USP-1086833 |
Calcium Gluconate Monohydrate (200 mg) (Calcium D-Gluconate Monohydrate) |
66905-23-5 |
|
2918160000 |
|
|
|
USP-1086866 |
Calcium (-)-Hydroxycitrate (150 mg) |
NA |
|
2918195000 |
|
|
|
USP-1086877 |
Calcium L-Threonate (500 mg) (Calcium (2R,3S)-2,3,4-trihydroxybutanoate) |
70753-61-6 |
|
2918195000 |
|
|
|
USP-1086888 |
Calcium Lactate (1 g) |
5743-47-5 |
|
2918110002 |
|
|
|
USP-1086902 |
Calcium Lactobionate (200 mg) |
110638-68-1 |
|
2918195000 |
|
|
|
USP-1086935 |
Calcium Levulinate (1 g) (AS) |
5743-49-7 |
|
2918300000 |
|
|
|
USP-1095517 |
Carbidopa Related Compound A (25 mg) (3-O-Methylcarbidopa) |
85933-19-3 |
|
2928002500 |
|
|
|
USP-1096019 |
Carbinoxamine Related Compound A (25 mg) ((4-Chlorophenyl)(pyridin-2-yl)methanone) |
6318-51-0 |
|
2933399095 |
|
|
|
USP-1096021 |
Carbinoxamine Related Compound B (25 mg) ((4-Chlorophenyl)(pyridin-2-yl)methanol) |
27652-89-7 |
|
2933399095 |
|
|
|
USP-1096032 |
Carbinoxamine Related Compound C (25 mg) (N,N-Dimethyl-2-[phenyl(pyridin-2-yl)methoxy]ethan-1-amine oxalate) |
N/A |
|
2933399095 |
|
|
|
USP-1304049 |
Heparin Sodium System Suitability (50 mg) |
N/A |
|
3822190000 |
|
|
|
USP-1304130 |
Low Molecular Weight Heparin for Boron Analysis (300 mg) |
9041/8/1 |
|
3001900190 |
|
|
|
USP-1304377 |
Hesperidin (200 mg) |
64726-90-5 |
|
2938900000 |
|
|
|
USP-1305008 |
Hexachlorophene (500 mg) |
70-30-4 |
UN2875 |
USP-1305303 |
Hexacosanol (100 mg) |
506-52-5 |
|
2905199095 |
|
|
|
USP-1305507 |
2E, 4E-Hexadienoic Acid Isobutylamide (25 mg) |
65937-49-7 |
|
2924190002 |
|
|
|
USP-1308307 |
Hexylresorcinol (200 mg) |
136-77-6 |
|
2907299000 |
|
|
|
USP-1308505 |
L-Histidine (200 mg) |
71-00-1 |
|
2933290000 |
|
|
|
USP-1308550 |
L-Histidine Monohydrochloride Monohydrate (200 mg) |
5934-29-2 |
|
2933290000 |
|
|
|
USP-1309009 |
Histamine Dihydrochloride (250 mg) |
56-92-8 |
|
2933290000 |
|
|
|
USP-1309911 |
Powdered Holy Basil Extract (1 g) |
91845-35-1 |
|
1302190200 |
|
|
|
USP-1310008 |
Homatropine Hydrobromide (200 mg) |
51-56-9 |
|
2939790000 |
|
|
|
USP-1311000 |
Homatropine Methylbromide (250 mg) |
80-49-9 |
|
2939800000 |
|
|
|
USP-1311500 |
Coagulation Factor VIIa (2 x 1.15 mg) (Eptacog Alfa (Activated)) |
102786-61-8 |
|
3002120090 |
|
|
|
USP-1313006 |
Hydralazine Hydrochloride (200 mg) |
304-20-1 |
UN2811 |
USP-1313210 |
Hydrastine (10 mg) |
118-08-1 |
|
2939800000 |
|
|
|
USP-1313254 |
4-Hydrazinylbenzenesulfonamide Hydrochloride (25 mg) |
17852-52-7 |
|
2935909550 |
|
|
|
USP-1314009 |
Hydrochlorothiazide (200 mg) |
58-93-5 |
|
2935904000 |
|
|
|
USP-1316004 |
Hydrocortisone (200 mg) |
50-23-7 |
UN2811 |
USP-1317007 |
Hydrocortisone Acetate (200 mg) |
1950/3/3 |
|
2937290000 |
|
|
|
USP-1333058 |
Hydroxyzine Related Compound A (25 mg) (1-[(4-Chlorophenyl)phenylmethyl]piperazine) |
303-26-4 |
|
2933599550 |
|
|
|
USP-1334006 |
Hydroxyzine Pamoate (500 mg) |
10246-75-0 |
|
2933595960 |
|
|
|
USP-1335009 |
Hyoscyamine Sulfate (125 mg) |
6835-16-1 |
UN1544 |
USP-1335010 |
Hyoscyamine Related Compound A (10 mg) (Norhyoscyamine Sulfate) |
N/A |
UN1544 |
USP-1335202 |
Hyperoside (50 mg) |
482-36-0 |
|
2938900000 |
|
|
|
USP-1335279 |
Hypromellose Acetate Succinate (100 mg) |
71138-97-1 |
|
3912390000 |
|
|
|
USP-1335304 |
Hypromellose Phthalate (100 mg) |
9050-31-1 |
|
3912390000 |
|
|
|
USP-1335417 |
Ibandronate Sodium (200 mg) |
138926-19-9 |
UN1759 |
USP-1335428 |
Ibandronate Related Compound A (25 mg) (3-[Methyl(pentyl)amino]propanoic acid hydrochloride) |
625120-81-2 |
|
2922498050 |
|
|
|
USP-1335508 |
Ibuprofen (750 mg) |
15687-27-1 |
|
2916399000 |
|
|
|
USP-1335596 |
Ibuprofen Related Compound J (25 mg) (2-(4-Isobutyrylphenyl)propanoic acid) |
65813-55-0 |
|
2917394000 |
|
|
|
USP-1335610 |
Ibutilide Fumarate (100 mg) |
122647-32-9 |
|
2935904000 |
|
|
|
USP-1335621 |
Ibutilide Related Compound A (20 mg) (N-Ethyl-N-heptyl-4-[4-(methylsulfonamido)phenyl]-4-oxobutanamide) |
100632-58-4 |
|
2935909550 |
|
|
|
USP-1335632 |
Ibutilide Related Compound B (20 mg) (N-Ethyl-N-heptyl-4-hydroxy-4-[4-(methylsulfonamido)phenyl]butanamide) |
160087-98-9 |
|
2935909550 |
|
|
|
USP-1335701 |
Idarubicin Hydrochloride (50 mg) |
57852-57-0 |
UN2811 |
USP-1336001 |
Idoxuridine (250 mg) |
54-42-2 |
|
2934990005 |
|
|
|
USP-1609024 |
Salicylic Acid Related Compound B (100 mg) (4-hydroxyisophthalic acid) |
636-46-4 |
|
2918290000 |
|
|
|
USP-1609534 |
Salidroside (25 mg) (2-(4-Hydroxyphenyl)ethyl-Beta-D-glucopyranoside) |
10338-51-9 |
|
2938900000 |
|
|
|
USP-1609589 |
Salmeterol Resolution Check (15 mg) |
N/A |
|
2922504500 |
|
|
|
USP-1609590 |
Salmeterol System Suitability (15 mg) (Mixture containing salmeterol xinafoate, salmeterol-N-alkyl and salmeterol related compound H) |
N/A |
|
3822190000 |
|
|
|
USP-1609603 |
Salmeterol Xinafoate (150 mg) |
94749-08-3 |
|
2922504500 |
|
|
|
USP-1609614 |
Salmeterol Related Compound A (20 mg) (4-[1-Hydroxy-2-(4-phenylbutylamino)ethyl]-2-(hydroxymethyl)phenol) |
N/A |
|
2922504500 |
|
|
|
USP-1609625 |
Salmeterol Related Compound B (3 x 1.3 mg) (4-{1-Hydroxy-2-[6-(4-phenylbutan-2-yloxy)hexylamino]ethyl}-2- |
108928-81-0 |
|
2922504500 |
|
|
|
USP-1609680 |
Salmeterol Related Compound H (30 mg) (1-Hydroxy-4-[2-hydroxy-5-(1-hydroxy-2-{[6-(4-phenylbutoxy)hexyl]amino}ethyl)benzyl]-2-naphthoic acid, monohydrate) |
N/A |
|
2922504500 |
|
|
|
USP-1609807 |
Salsalate (150 mg) |
552-94-3 |
|
2918230000 |
|
|
|
USP-1609818 |
Salvianolic Acid B (25 mg) |
121521-90-2 |
|
2938900000 |
|
|
|
USP-1609829 |
Saquinavir Mesylate (200 mg) |
149845-06-7 |
|
2933492250 |
|
|
|
USP-1609831 |
Saquinavir Related Compound A (25 mg) (N-tert-butyl-decahydro-2-[2(R)-hydroxy-4-phenyl-3(S)-[[N-(2-quinolylcarbonyl)-D-asparaginyl]amino]butyl]-(4aS,8aS)-isoquinoline-3(S)-carboxamide) |
N/A |
|
2933497050 |
|
|
|
USP-1609840 |
Saposhnikovia Divaricata Root Dry Extract (1 g) |
NA |
|
1302190200 |
|
|
|
USP-1609895 |
Schisandrin (15 mg) |
7432-28-2 |
|
2909490000 |
|
|
|
USP-1609909 |
Schisandra chinensis Fruit Dry Extract (1 g) |
N/A |
|
1302190200 |
|
|
|
USP-1610001 |
Scopolamine Hydrobromide (500 mg) |
N/A |
UN1544 |
USP-1610090 |
Scopoletin (20 mg) |
92-61-5 |
|
2932206000 |
|
|
|
USP-1610307 |
Scutellaria Baicalensis Root Dry Extract (1 g) |
N/A |
|
1302190200 |
|
|
|
USP-1611117 |
Secoxyloganin (50 mg) ([(2S,3R,4S)-2-(beta-D-Glucopyranosyloxy)-5-(methoxycarbonyl)-3-vinyl-3,4-dihydro-2H-pyran-4-yl]acetic acid) |
58822-47-2 |
|
2938900000 |
|
|
|
USP-1611729 |
Selamectin (350 mg) |
220119-17-5 |
UN3077 |
USP-1611900 |
Selegiline Hydrochloride (200 mg) |
14611-52-0 |
|
2921490002 |
|
|
|
USP-1611944 |
Selegiline Related Compound D (15 mg) ((R)-N-(1-Phenylpropan-2-yl)prop-2-yn-1-amine hydrochloride) |
115586-38-4 |
|
2921490002 |
|
|
|
USP-1611955 |
Selenomethionine (100 mg) |
3211-76-5 |
|
2931909000 |
|
|
|
USP-1611966 |
Selenium Sulfide (200 mg) |
7488-56-4 |
|
2813906000 |
|
|
|
USP-1612007 |
Sennosides (500 mg) |
N/A |
|
2938900000 |
|
|
|
USP-1612018 |
Sennoside A (20 mg) ((9R,9’R)-5,5′-Bis(beta-d-glucopyranosyloxy)-4,4′-dihydroxy-10,10′-dioxo-9,9′,10,10′-tetrahydro-9,9′-bianthracene-2,2′-dicarboxylic acid) |
81-27-6 |
|
2938900000 |
|
|
|
USP-1612029 |
Sennoside B (20 mg) |
128-57-4 |
|
2938900000 |
|
|
|
USP-1612415 |
Sesame Oil Related Compound A (12 mg/vial; 2 vials) (1,2-dilinoleoyl-3-oleoyl-rac-glycerol) (OLL) |
2190-21-8 |
|
1516200100 |
|
|
|